ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.
한글목차
근시 치료 시장 규모는 향후 수년간 강력한 성장세를 보일 것으로 예상되며, 2029년에는 연평균 9.5%의 연평균 복합 성장률(CAGR)로 281억 6,000만 달러에 달할 것으로 예측됩니다. 예측 기간 중 예상되는 성장은 원거리 시력 장애의 유병률 증가, 디지털 플랫폼 사용 증가, 의료 인프라 확대, 근시 유병률 증가, 시력 상실 사례 증가에 기인합니다. 이 기간 중 예상되는 주요 동향으로는 경질 가스 투과성 콘택트렌즈 채택, 빛 기반 치료법의 발전, 유전적 요인에 대한 혁신적인 연구, 디지털 플랫폼과 용도의 통합, 아트로핀 점안제 개발 등이 있습니다.
근시 치료 시장의 성장은 스크린 타임 증가에 의해 주도될 것으로 예측됩니다. 스크린 타임은 스마트폰, 태블릿, 컴퓨터, TV 등 스크린이 있는 기기를 사용하는 시간을 의미합니다. 이러한 증가 요인으로는 스트리밍 서비스, 소셜미디어 플랫폼, 원격 근무, 가상 회의의 인기 증가 등이 있습니다. 근시 치료는 장시간 화면 사용으로 인한 눈의 피로와 불편함을 완화하고 시각적 선명도, 집중력 및 전반적인 편안함을 향상시키는 데 도움이 될 수 있습니다. 예를 들어 2024년 10월 미국 질병통제예방센터(CDC)의 데이터에 따르면 2021년 7월부터 2023년 12월까지 12-17세 청소년의 50.4%가 매일 4시간 이상 스크린을 본다고 답했습니다. 또한 22.8%가 3시간, 17.8%가 2시간, 6.1%가 1시간, 3.0%가 하루 1시간 미만으로 스크린에 접속하는 것으로 나타났습니다. 이러한 스크린 이용 시간 추세가 근시 치료 시장 확대를 이끄는 중요한 요인이 되고 있습니다.
근시 치료 시장의 주요 기업은 진단 정확도 향상과 개인 맞춤형 치료를 제공하기 위해 광학식 바이오미터와 같은 혁신적인 제품 개발에 주력하고 있습니다. 광학식 바이오미터는 빛을 이용하여 축 길이, 각막 곡률 등의 안구 파라미터를 평가하여 안질환의 진단 및 모니터링에 도움을 줍니다. 예를 들어 2023년 2월 일본의 안과 제품 전문 기업인 니혼덴산(주)은 AL-Scan M과 MV-1 장비를 발표했는데, AL-Scan M은 3D 자동 추적 및 자동 촬영 기능을 갖추고 있으며, 자동 굴절계와 유사한 효율적이고 사용자 친화적인 측정이 가능합니다. 가능합니다. AL-Scan M은 근시 진행을 추적하는 데 필수적인 정확한 축 길이 측정을 위해 설계되었으며, 특히 젊은 환자들의 처리량을 향상시켜 줍니다. 또한 MV-1 Myopia Viewer 소프트웨어와 원활하게 통합되어 치료 이력 및 환자 행동을 쉽게 추적할 수 있습니다.
목차
제1장 개요
제2장 시장의 특징
제3장 시장 동향과 전략
제4장 시장 - 거시경제 시나리오 금리, 인플레이션, 지정학, 신형 코로나바이러스의 영향과 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오
제5장 세계의 성장 분석과 전략 분석 프레임워크
세계의 근시 치료 PESTEL 분석(정치, 사회, 기술, 환경, 법적 요인, 촉진요인과 억제요인)
최종 용도 산업의 분석
세계의 근시 치료 시장 : 성장률 분석
세계의 근시 치료 시장 실적 : 규모와 성장, 2019-2024
세계의 근시 치료 시장 예측 : 규모와 성장, 2024-2029, 2034F
세계 근시 치료 TAM(Total Addressable Market)
제6장 시장 세분화
세계의 근시 치료 시장 : 유형별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
단순 근시
고도 근시
병적 근시
세계의 근시 치료 시장 : 치료별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
안경
콘택트렌즈
굴절 교정 수술
LASIK(Laser-Assisted In Situ Keratomileusis)
굴절 교정 각막 절제술(PRK)
Ortho-K(Orthokeratology)
세계의 근시 치료 시장 : 투여 경로별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
경구
비경구
기타 투여 경로
세계의 근시 치료 시장 : 유통 채널별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
직접 입찰
소매 판매량
기타 유통 채널
세계의 근시 치료 시장 : 최종사용자별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
병원 또는 임상 검사실
의사 진료소
표준실험실
기타 최종사용자
세계의 근시 치료 시장, 단순 근시의 서브 세분화, 유형별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
경도 근시
중도 근시
세계의 근시 치료 시장, 고도 근시의 서브 세분화, 유형별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
Severe Myopia
Very Severe Myopia
세계의 근시 치료 시장, 병적 근시의 서브 세분화, 유형별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
변성 근시
악성 근시
제7장 지역별·국가별 분석
세계의 근시 치료 시장 : 지역별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
세계의 근시 치료 시장 : 국가별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
제8장 아시아태평양 시장
제9장 중국 시장
제10장 인도 시장
제11장 일본 시장
제12장 호주 시장
제13장 인도네시아 시장
제14장 한국 시장
제15장 서유럽 시장
제16장 영국 시장
제17장 독일 시장
제18장 프랑스 시장
제19장 이탈리아 시장
제20장 스페인 시장
제21장 동유럽 시장
제22장 러시아 시장
제23장 북미 시장
제24장 미국 시장
제25장 캐나다 시장
제26장 남미 시장
제27장 브라질 시장
제28장 중동 시장
제29장 아프리카 시장
제30장 경쟁 구도와 기업 개요
근시 치료 시장 : 경쟁 구도
근시 치료 시장 : 기업 개요
Regeneron Pharmaceuticals Inc. Overview, Products and Services, Strategy and Financial Analysis
Alcon Inc. Overview, Products and Services, Strategy and Financial Analysis
Bausch Health Companies Inc. Overview, Products and Services, Strategy and Financial Analysis
Hoya Corporation Overview, Products and Services, Strategy and Financial Analysis
Johnson & Johnson Vision Care Inc. Overview, Products and Services, Strategy and Financial Analysis
제31장 기타 대기업과 혁신적 기업
CooperVision Inc.
Menicon Co. Ltd.
Topcon Healthcare Inc.
Essilor Ltd.
NIDEK CO. LTD.
SightGlass Vision Inc.
SCHWIND eye-tech-solutions GmbH
Visioneering Technologies Inc.
MEDMONT INTERNATIONAL PTY LTD.
Vyluma Inc.
Haag-Streit Holding AG
NovaSight Ltd.
Euclid Vision Corporation
Treehouse Eyes LLC
Sydnexis Inc.
제32장 세계의 시장 경쟁 벤치마킹과 대시보드
제33장 주요 합병과 인수
제34장 최근 시장 동향
제35장 시장의 잠재력이 높은 국가, 부문, 전략
근시 치료 시장 2029 : 새로운 기회를 제공하는 국가
근시 치료 시장 2029 : 새로운 기회를 제공하는 부문
근시 치료 시장 2029 : 성장 전략
시장 동향에 기반한 전략
경쟁의 전략
제36장 부록
KSA
영문 목차
영문목차
Myopia treatment involves medical or corrective methods designed to address or manage myopia, commonly known as nearsightedness. This refractive error causes distant objects to appear blurry while nearby objects remain clear. The primary aim of myopia treatment is to enhance vision and improve quality of life by correcting refractive errors. Additionally, it focuses on controlling the progression of myopia, thereby reducing long-term dependence on corrective lenses for better vision health.
The primary categories of myopia treated include simple myopia, high myopia, and pathological myopia. Simple myopia, caused by an elongated eyeball or an overly curved cornea, results in blurry distant vision and can be treated with corrective lenses or refractive surgery. Treatment options include eyeglasses, contact lenses, refractive surgery, laser-assisted in situ keratomileusis (LASIK), photorefractive keratectomy (PRK), and orthokeratology (Ortho-K). These treatments are administered through various methods, such as oral or parenteral routes, among others. Distribution channels include direct tender and retail sales, catering to end users such as hospitals, clinical laboratories, physician offices, and reference laboratories.
The myopia treatment market research report is one of a series of new reports from The Business Research Company that provides myopia treatment market statistics, including the myopia treatment industry global market size, regional shares, competitors with the myopia treatment market share, detailed myopia treatment market segments, market trends, and opportunities, and any further data you may need to thrive in the myopia treatment industry. This myopia treatment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.
The myopia treatment market size has grown strongly in recent years. It will grow from $17.82 billion in 2024 to $19.58 billion in 2025 at a compound annual growth rate (CAGR) of 9.9%. The growth observed during the historical period can be attributed to factors such as a growing geriatric population, heightened government awareness initiatives, increased public awareness about myopia treatment, greater investment in research and development, and a rising prevalence of distance vision impairment.
The myopia treatment market size is expected to see strong growth in the next few years. It will grow to $28.16 billion in 2029 at a compound annual growth rate (CAGR) of 9.5%. The growth projected for the forecast period can be attributed to the rising prevalence of distance vision impairment, increased utilization of digital platforms, expanding healthcare infrastructure, a growing incidence of myopia, and an increase in cases of vision loss. Key trends anticipated during this period include the adoption of rigid gas-permeable contact lenses, advancements in light-based therapies, innovative research into genetic factors, the integration of digital platforms and applications, and developments in atropine eye drop formulations.
The growth of the myopia treatment market is anticipated to be driven by the rising levels of screen time. Screen time refers to the duration individuals spend using devices equipped with screens, such as smartphones, tablets, computers, and televisions. Factors contributing to this increase include the growing popularity of streaming services, social media platforms, remote work, and virtual meetings. Myopia treatments are beneficial in mitigating eye strain and discomfort caused by extended screen use, enhancing visual clarity, focus, and overall comfort. For example, in October 2024, data from the Centers for Disease Control and Prevention (CDC), a US-based government agency, revealed that between July 2021 and December 2023, 50.4% of teenagers aged 12-17 reported spending four or more hours daily on screens. Additionally, 22.8% spent three hours, 17.8% spent two hours, 6.1% spent one hour, and 3.0% spent less than one hour per day on screens. This growing screen time trend is a significant factor fueling the expansion of the myopia treatment market.
Leading companies in the myopia treatment market are concentrating on developing innovative products, such as optical biometers, to improve diagnostic accuracy and provide personalized treatments. Optical biometers utilize light to assess eye parameters such as axial length and corneal curvature, aiding in the diagnosis and monitoring of eye conditions. For example, in February 2023, NIDEK Co., Ltd., a Japanese company specializing in ophthalmic products, introduced the AL-Scan M and MV-1 devices. The AL-Scan M features 3D auto-tracking and auto-shot capabilities, allowing for efficient and user-friendly measurements similar to those of an autorefractor. These enhancements boost patient throughput, especially for younger patients. The AL-Scan M is designed for precise axial length measurements, which are vital for tracking myopia progression. Additionally, it integrates smoothly with the MV-1 Myopia Viewer software, facilitating the tracking of treatment history and patient behavior.
In January 2023, CooperVision, Inc., a US-based producer of soft contact lenses, acquired SynergEyes, Inc. for an undisclosed sum. This acquisition is intended to bolster CooperVision's specialty contact lens portfolio and reinforce its standing in the advanced ocular care market. SynergEyes, Inc., also based in the US, specializes in manufacturing contact lenses designed to address myopia progression.
Major players in the myopia treatment market are Regeneron Pharmaceuticals Inc., Alcon Inc., Bausch Health Companies Inc., Hoya Corporation, Johnson & Johnson Vision Care Inc., CooperVision Inc., Menicon Co. Ltd., Topcon Healthcare Inc., Essilor Ltd., NIDEK CO. LTD., SightGlass Vision Inc., SCHWIND eye-tech-solutions GmbH, Visioneering Technologies Inc., MEDMONT INTERNATIONAL PTY LTD., Vyluma Inc., Haag-Streit Holding AG, NovaSight Ltd., Euclid Vision Corporation, Treehouse Eyes LLC, Sydnexis Inc., Neurobit Technologies Co. Ltd., Kubota Pharmaceutical Holdings Co. Ltd.
Asia Pacific was the largest region in the myopia treatment market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in myopia treatment report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
The countries covered in the myopia treatment market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The myopia treatment market consists of revenues earned by entities by providing services such as myopia control programs, vision therapy, and lifestyle and behavioral guidance. The market value includes the value of related goods sold by the service provider or included within the service offering. The myopia treatment market includes sales of prescription glasses, atropine drops, and myopia control glasses. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Myopia Treatment Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on myopia treatment market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for myopia treatment ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The myopia treatment market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:
The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.
Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope
Markets Covered:1) By Type: Simple Myopia; High Myopia; Pathological Myopia
2) By Treatment: Eyeglasses; Contact Lenses; Refractive Surgery; Laser-Assisted In Situ Keratomileusis (LASIK); Photorefractive Keratectomy (PRK); Orthokeratology (Ortho-K)
3) By Route Of Administration: Oral; Parenteral; Other Routes Of Administration
4) By Distribution Channel: Direct Tender; Retail Sales; Other Distribution Channels
5) By End-User: Hospital Or Clinical Laboratories; Physician Offices; Reference Laboratories; Other End-Users
Subsegments:
1) By Simple Myopia: Mild Myopia; Moderate Myopia
2) By High Myopia: Severe Myopia; Very Severe Myopia
3) By Pathological Myopia: Degenerative Myopia; Malignant Myopia
Companies Mentioned:Regeneron Pharmaceuticals Inc.; Alcon Inc.; Bausch Health Companies Inc.; Hoya Corporation; Johnson & Johnson Vision Care Inc.
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery format: PDF, Word and Excel Data Dashboard.
Table of Contents
1. Executive Summary
2. Myopia Treatment Market Characteristics
3. Myopia Treatment Market Trends And Strategies
4. Myopia Treatment Market - Macro Economic Scenario Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market
5. Global Myopia Treatment Growth Analysis And Strategic Analysis Framework
5.1. Global Myopia Treatment PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis Of End Use Industries
5.3. Global Myopia Treatment Market Growth Rate Analysis
5.4. Global Myopia Treatment Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
5.5. Global Myopia Treatment Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
5.6. Global Myopia Treatment Total Addressable Market (TAM)
6. Myopia Treatment Market Segmentation
6.1. Global Myopia Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Simple Myopia
High Myopia
Pathological Myopia
6.2. Global Myopia Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Eyeglasses
Contact Lenses
Refractive Surgery
Laser-Assisted In Situ Keratomileusis (LASIK)
Photorefractive Keratectomy (PRK)
Orthokeratology (Ortho-K)
6.3. Global Myopia Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Oral
Parenteral
Other Routes Of Administration
6.4. Global Myopia Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Direct Tender
Retail Sales
Other Distribution Channels
6.5. Global Myopia Treatment Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Hospital Or Clinical Laboratories
Physician Offices
Reference Laboratories
Other End-Users
6.6. Global Myopia Treatment Market, Sub-Segmentation Of Simple Myopia, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Mild Myopia
Moderate Myopia
6.7. Global Myopia Treatment Market, Sub-Segmentation Of High Myopia, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Severe Myopia
Very Severe Myopia
6.8. Global Myopia Treatment Market, Sub-Segmentation Of Pathological Myopia, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Degenerative Myopia
Malignant Myopia
7. Myopia Treatment Market Regional And Country Analysis
7.1. Global Myopia Treatment Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
7.2. Global Myopia Treatment Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
